Peptiva

Research Compound AOD-9604

€51,00

€51,00 €60,00

FOR IN VITRO LABORATORY RESEARCH ONLY.
Not intended for personal, clinical, diagnostic or veterinary use, or for administration to humans or animals.

Delivery and payment for your destination

Delivery country

BOX NOW parcel locker: €1.59 · estimated 1–2 business days. DPD to an address: €4.43; delivery estimate at checkout.

Cash on delivery where offered. BOX NOW payment is digital via a link before collection; lockers do not accept cash.

DPD: €12.99 · delivery estimate is shown at checkout.

A DPD cash-on-delivery option is available for this country when offered at checkout.

DPD: €12.99 · delivery estimate is shown at checkout.

A Stripe payment link is sent by email. Payment is confirmed before dispatch.

For other destinations, first request confirmation of shipping and product availability. Send enquiry

Information preview. Select your delivery address at checkout.

Full shipping terms

Free DPD shipping from €250 in product value where offered. Final costs and any additional fees are shown before order confirmation. Delivery time starts at carrier handover and depends on product availability.

Full shipping terms →

MAIN RESEARCH AREAS Research profile

Lipolytic signalling Primary

Adipocyte biology Very common

In vitro lipid metabolism Common

Energy homeostasis Secondary

Editorial map of the main themes found in the scientific literature. Bar length is not a statistical score, efficacy rating, or indication for human use.

Product information in one place

Specifications and available formats

Strength	5 mg
Format	Lyophilised vial · Research dispenser

This is an overview of options. Select your required variant and its price above.

Description and research information

Research Compound AOD-9604 is a laboratory material for analytical and in vitro work.

What is AOD-9604?

AOD-9604 is a synthetic 16-amino-acid peptide corresponding to residues 177–191 of human growth hormone, with an additional tyrosine at the N-terminus. The molecular weight is approximately 1.8 kDa. It is closely related to HGH Fragment 176-191.

Research background

The molecule originates from research on C-terminal growth hormone fragments at Monash University and was developed by the Australian company Metabolic Pharmaceuticals. Development as a medicine for metabolic indications was discontinued after clinical trials failed to show sufficient efficacy.

Mechanism and scientific context

In adipocyte and animal models AOD-9604 is associated with regulation of lipolysis and lipogenesis. According to published work it does not show a significant effect on IGF-1 or growth, distinguishing it from full-length somatropin. The receptor mechanism has not been fully elucidated.

Main research areas

growth hormone fragments
adipocyte biology
lipid metabolism in models
separating metabolic from growth-related effects of GH

Level of evidence

Preclinical data and clinical trials that did not confirm efficacy. The molecule is not an approved medicine.

Research use only: for laboratory, analytical and in vitro research only; not for use in humans or animals. Guidance on batch documentation is available in our COA guide.

Storage and handling

Follow the label and documentation for the specific batch. Conditions depend on the material and format; do not assume one storage regime for all products. Request missing information before ordering.

Documentation and lot

Request available records for the exact product, variant and lot. A product name alone does not link a report to the supplied batch.

Request documentation

Quality and documentation →